3rd Quarter - Report

AVIVA STRATEGIES (FKA MGB CONSULTING) for ENDEAVOR BIOMEDICINES

Firm
Client
Income
$51,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FAIR Act HR 7953 FDA Modernization

LobbyistCovered position, as disclosed
MAX GABRIEL BRONSTEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 7953 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.